Sonoma Biotherapeutics sonomabio.com


Sonoma Biotherape.utics develops adoptive Treg therapies cell for autoimmune and degenerative diseases.

Sonoma Biotherape.utics develops adoptive Treg therapies cell for autoimmune and degenerative diseases.

Company (Alive / Active)

Phone:

Fax:

400 E. Jamie Ct
202
San Francisco, 94080
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Sonoma Biotherapeutics $70M Sep 30, 2020

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Sonoma Biotherapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 11 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Quell Therapeutics

London, England, United Kingdom
Alive / ActiveQuell Therapeutics is a London-based biotech company developing immune cell therapies to target transplant rejection and autoimmune and inflammatory diseases.Login to see details

Patents

Title Application Date Patent Date Status
(Patent / Application)